Everything below concerns dihexa. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
| Property | Value | Notes |
|---|---|---|
| Molecular target | HGF/c-Met pathway | Proposed, not fully confirmed |
| Research models | Rodent cognition assays | Results vary by study |
| Human trial data | Limited or absent | No approved clinical use |
| Metabolic stability | Uncertain | Peptide degradation possible |
| Blood-brain barrier | Under investigation | Lipophilicity may affect distribution |
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
By the end of the 1960s, peptides were phased out as drug candidates. Miguel Ondetti moved to the gastrointestinal hormone group in the mid 1960s. The first hormone to be studied by Ondetti's group was cholecystokinin, a digestion hormone. This product presented unique challenges because of the small amounts used in reactions. Unfortunately, bioassays were not quantitative enough to use for results and chemical reactions did not run well as such low amounts.
== Veterinary use == Methadone is a common perioperative analgesic in cats and dogs with a variety of routes of administration. Methadone in combination with acepromazine provides greater sedation than the equivalent combination involving morphine or butorphanol. Methadone's depressive effect on the cardiovascular system is approximately twice as strong as morphine. Methadone is contradicated for gastroduodenoscopy. Methadone provides greater analgesia than buprenorphine for orthopaedic and ovariohysterectomy procedures in dogs. Fluconazole and methadone given concurrently as a subcutaneous administration twice over a 6 hour period can provide analgesia for 12–24 hours. Methadone can be used for sedation in horses but is less effective than butorphanol, it can be combined with detomidine, which improves efficacy but can cause ataxia although the combination with detomidine has significantly less cardiovascular depressive effects than a combination with acepromazine. Methadone may be more effective as an analgesic in horses when adiminstered parenterally or epidurally as opposed to intravenously. Opioids are uncommon for livestock due to legislation surrounding usage but intravenous methadone is an effective analgesic in sheep and epidural methadone is an effective analgesic in cattle and sheep. Methadone comes as levomethadone and dextromethadone with the former sometimes combined with the anti-cholinergic fenpipramide. Oral methadone is poorly absorbed in most species.
=== Analogues === In addition to deupsilocin, Helus Pharma has also patented other deuterated psilocin isotopologues. Other deuterated drugs related to deupsilocin include the deuterated dimethyltryptamine (DMT) isotopologues deudimethyltryptamine (HLP004; CYB004; DMT-d10; deudimethyltryptamine) and SPL028 (D2-DMT) and the deuterated phenethylamine HLP005 (CYB005).
=== Africa === Fake antimalarial medication has been threatening efforts to control malaria in Africa, including the development of antimalarial resistance. Other medicines have been documented to be of dangerously poor quality. In October 2022, the deaths of at least 70 children in Gambia were linked to cough syrups manufactured in India, which had high levels of diethylene glycol and ethylene glycol. There were delays in government response, despite doctors pressing for this. In 2011, according to the World Health Organization (WHO), 64% of Nigeria's imported antimalarial medication drugs were fake. By 2023, the problem of substandard and falsified medicines had lessened somewhat since the peak. Nigeria is Africa's largest drugs market, and over 70% of its drugs are imported from India and China, considered the "biggest source of fakes." One response has been attempts to bolster domestic production of medicines, but challenges include insecurity and unstable electricity. There have been investments in technologies to increase detection and verification of poor-quality medicines. In 2018, Tramadol, a powerful and addictive opioid, became a major problem. A huge black market has emerged, and an increasing number of addicts overdose and die.
Sources: en.wikipedia.org
=== EC 1.2.7 With an iron–sulfur protein as acceptor === EC 1.2.7.1: pyruvate synthase EC 1.2.7.2: Now included with EC 1.2.7.1, pyruvate synthase. EC 1.2.7.3: 2-oxoglutarate synthase EC 1.2.7.4: anaerobic carbon monoxide dehydrogenase EC 1.2.7.5: aldehyde ferredoxin oxidoreductase EC 1.2.7.6: glyceraldehyde-3-phosphate dehydrogenase (ferredoxin) EC 1.2.7.7: 3-methyl-2-oxobutanoate dehydrogenase (ferredoxin) EC 1.2.7.8: indolepyruvate ferredoxin oxidoreductase EC 1.2.7.9: deleted, identical to EC 1.2.7.3, 2-oxoglutarate synthase EC 1.2.7.10: oxalate oxidoreductase EC 1.2.7.11: 2-oxoacid oxidoreductase (ferredoxin) EC 1.2.7.12: formylmethanofuran dehydrogenase
== Clinical trials == Clinical and experimental studies on gastropod inspired adhesives report results across a range of applications such as skin treatment and wound healing. In one human study using Cornu aspersum slime, 27 participants were divided into four groups based on age and gender. The Cornu Aspersum Muller slime and a commercial slime were applied to opposite sides of the face once daily for 15 days. Female participants applied the slime at the corners of their eyes, while male participants applied it to the forehead. The results indicated that some women experienced increased skin firmness when using Cornu aspersum, with more noticeable effects in participants under forty years old compared to those above that age. For male participants, the results were less statistically significant overall. This was also supported by subcutaneous implantation and myocardium attachment studies in rats. One finding was that the gastropod-inspired adhesive produced a lower inflammatory response compared to some existing adhesive methods under the tested conditions. Overall, these findings highlight observed differences between gastropod inspired adhesives and traditional wound dressings and adhesives, which have been reported to exhibit reduced adhesion in wet conditions.
Classification and Evolution Regulation, Development, and Molecular Diversity Aquatic Environments and Populations Ecology and Biodiversity Management History of Earth Men, Nature, and Societies, and Prehistory The diffusion departments are:
It is not significantly produced in nuclear reactors because 243Pu has a short half-life, but some is produced in nuclear explosions. 244Pu has been found in interstellar space and has the second longest half-life of any non-primordial radioisotope.
== Function == NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP and BNP, respectively). It is localized in the kidney where it results in natriuresis upon binding to natriuretic peptides. However, it is found in even greater quantity in the lungs and adipocytes.
Sources: en.wikipedia.org
The Port of Holyhead is a busy ferry port. Stena Line, Northern Europe's biggest ferry company, operates from the port, as do Irish Ferries. Ferries sail to Dublin. Holyhead railway station is the terminus of the North Wales Coast Line and is currently served by Avanti West Coast and Transport for Wales services. Avanti West Coast runs direct trains to London Euston via Crewe and Transport for Wales operate direct trains to Cardiff and Birmingham International, via Wrexham and Shrewsbury; they also operate on the route to Manchester Piccadilly, via Warrington.
Trypanothione is an unusual form of glutathione containing two molecules of glutathione joined by a spermidine (polyamine) linker. It is found in parasitic protozoa such as leishmania and trypanosomes. These protozoal parasites are the cause of leishmaniasis, sleeping sickness and Chagas' disease. Trypanothione was discovered by Alan Fairlamb. Its structure was proven by chemical synthesis. It is present mainly in the Kinetoplastida but can be found in other parasitic protozoa such as Entamoeba histolytica. Since this thiol is absent from humans and is essential for the survival of the parasites, the enzymes that make and use this molecule are targets for the development of new drugs to treat these diseases. Trypanothione-dependent enzymes include reductases, peroxidases, glyoxalases and transferases. Trypanothione-disulfide reductase (TryR) was the first trypanothione-dependent enzyme to be discovered (EC 1.8.1.12). It is an NADPH-dependent flavoenzyme that reduces trypanothione disulfide. TryR is essential for survival of these parasites both in vitro and in the human host. A major function of trypanothione is in the defence against oxidative stress. Here, trypanothione-dependent enzymes such as tryparedoxin peroxidase (TryP) reduce peroxides using electrons donated either directly from trypanothione, or via the redox intermediate tryparedoxin (TryX). Trypanothione-dependent hydrogen peroxide metabolism is particularly important in these organisms because they lack catalase.
This enzyme is an excellent drug target because it is essential, is accessible from the periplasm, and has no equivalent in mammalian cells. DD-Transpeptidase is the target protein of β-lactam antibiotics (e.g. penicillin). This is because the structure of the β-lactam closely resembles the D-ala-D-ala residue. β-Lactams exert their effect by competitively inactivating the serine DD-transpeptidase catalytic site. Penicillin is a cyclic analogue of the D-Ala-D-Ala terminated carbonyl donors, therefore in the presence of this antibiotic, the reaction stops at the level of the serine ester-linked penicilloyl enzyme. Thus β-lactam antibiotics force these enzymes to behave like penicillin binding proteins. Kinetically, the interaction between the DD-peptidase and β-lactams is a three-step reaction:
=== Role of U.S. Secretary of State Marco Rubio === On February 3, 2025, Secretary of State Marco Rubio announced his appointment as Acting Administrator of USAID by President Trump and that USAID was being merged into the State Department. The legality of these actions is disputed given the mandate for the agency's creation in the Foreign Assistance Act.It was announced that on February 6, 2025, at 11:59 pm (EST) all USAID direct hire personnel would be placed on administrative leave globally, with the exception of designated personnel responsible for mission-critical functions, core leadership and specially designated programs.
=== Medical === Tracking expression has allowed for multiple investigations into the progression of diseased cells. Reporter genes have shown to provide critical insight into genes upregulated in cancer regulatory pathways as well as the identification into oncogenes and tumor suppressor genes. These have been used for further research into the development of therapeutics to stop further disease progression and metastasis. Gene therapy has also been tracked through the use of reporter genes. This allows for the monitoring of gene therapy vectors to see if they are achieving intended results as well as to monitor patient safety for short and long term periods. Therapeutics developed have benefited from the use of reporter genres such as a dual-reporter system developed for CRISPR/Cas9 models to monitor progression and success and benefits of being gene editing tools.
Sources: en.wikipedia.org
It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.
Published human trials are lacking. Most data come from cell cultures and animal models. Therefore, clinical effects and safety in people are uncertain.
It has been promoted in online communities for cognitive enhancement. That discussion is based largely on preclinical findings. It does not constitute evidence of efficacy or safety.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.